Cardiovascular Drugs Practice Questions

Q: Monday disease is associated with exposure to which class of drugs?

Nitrates. **Explanation:** **Monday Disease** is a classic phenomenon associated with industrial exposure to **Nitrates** (specifically nitroglycerin and ethylene glycol dinitrate) in explosives factories. **Why Nitrates are the correct answer:** Workers in these factories develop a high degree of **tolerance** to the vasodilatory effects of nitrates during the workweek. By the weekend, when they are away from the exposure, this tolerance is lost. Upon returning to work on **Monday**, the re-exposure causes sudden, intense vasodilation, leading to severe headaches (due to meningeal artery dilation), dizziness, and tachycardia. This cycle of losing and regaining tolerance is the hallmark of "Monday Disease." **Why other options are incorrect:** * **Beta blockers:** These drugs are used to manage heart rate and blood pressure; they do not cause industrial tolerance-withdrawal syndromes like nitrates. * **Calcium channel blockers (CCBs):** While CCBs cause vasodilation, they are not associated with the rapid tolerance and "weekend-reset" phenomenon seen in industrial nitrate exposure. * **Potassium channel openers:** Drugs like Minoxidil or Nicorandil cause vasodilation but are not used in the industrial manufacturing processes linked to this specific occupational hazard. **High-Yield Clinical Pearls for NEET-PG:** 1. **Tolerance Management:** To prevent nitrate tolerance in clinical practice, a **"Nitrate-free interval"** of 8–12 hours (usually at night) is mandatory. 2. **Mechanism:** Nitrates work by releasing **Nitric Oxide (NO)**, which increases **cGMP**, leading to dephosphorylation of myosin light chains and vascular smooth muscle relaxation. 3. **Drug Interaction:** Nitrates are strictly contraindicated with **Sildenafil** (PDE-5 inhibitors) as the combination can cause life-threatening hypotension.

Q: Which class of antihypertensive medications is primarily used in the management of angina pectoris?

Beta blocker. **Explanation:** **Why Beta Blockers are the Correct Choice:** Beta-blockers (e.g., Atenolol, Metoprolol) are the first-line antihypertensive agents for patients with comorbid stable angina. Their primary mechanism involves blocking $\beta_1$ receptors in the heart, leading to a decrease in heart rate (**negative chronotropy**) and myocardial contractility (**negative inotropy**). This significantly reduces **myocardial oxygen demand**. Additionally, by slowing the heart rate, they increase the duration of diastole, which improves coronary perfusion. **Analysis of Incorrect Options:** * **Alpha-blockers (A):** These cause peripheral vasodilation. While they lower blood pressure, they often trigger **reflex tachycardia**, which increases oxygen demand and can worsen anginal symptoms. * **Diuretics (C):** These reduce blood pressure by decreasing plasma volume. They have no direct effect on myocardial oxygen supply or demand and are not used for the management of angina. * **ACE Inhibitors (D):** These are excellent for hypertension, heart failure, and diabetic nephropathy. While they provide cardioprotection post-MI, they do not have direct anti-anginal properties (they don't reduce heart rate or contractility). **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Angina:** Beta-blockers are the drugs of choice for the chronic prophylaxis of stable angina. * **Contraindication:** Avoid beta-blockers in **Prinzmetal (variant) angina**, as they can lead to unopposed alpha-mediated coronary vasospasm. * **Goal:** In angina patients, the dose should be titrated to maintain a resting heart rate of 55–60 bpm. * **Sudden Withdrawal:** Never stop beta-blockers abruptly; it can precipitate rebound hypertension or myocardial infarction due to receptor up-regulation.

Q: Which of the following conditions enhances digitalis toxicity?

Hyperkalemia. **Explanation** Digitalis (Digoxin) works by inhibiting the **Na⁺/K⁺-ATPase pump** on cardiac myocytes [1]. The correct answer is **Hyperkalemia** because potassium and digoxin compete for the same binding site on this pump [1]. 1. **Why Hyperkalemia is the correct answer (Mechanism):** While *hypokalemia* is the most common electrolyte trigger for toxicity (due to increased digoxin binding) [3], **hyperkalemia** is the most significant indicator of **acute, severe digitalis poisoning**. When digoxin inhibits a massive number of Na⁺/K⁺-ATPase pumps simultaneously, potassium cannot enter the cells, leading to extracellular accumulation. Therefore, a high serum potassium level in the context of digitalis overdose is a marker of "total body pump failure" and is a strong predictor of mortality. 2. **Analysis of Other Options:** * **Renal Failure:** Digoxin is primarily excreted unchanged by the kidneys. Renal impairment increases the half-life and plasma concentration, leading to toxicity. * **Hypercalcemia:** Calcium and Digoxin have synergistic effects on the heart. High calcium facilitates "calcium overload," increasing the risk of arrhythmias (Stone Heart phenomenon). * **Hypomagnesemia:** Magnesium is a cofactor for the Na⁺/K⁺-ATPase pump. Low levels sensitize the myocardium to digoxin-induced arrhythmias. **High-Yield Clinical Pearls for NEET-PG:** * **Most common arrhythmia:** Ventricular Bigeminy [2]. * **Most characteristic arrhythmia:** Atrial Tachycardia with AV Block. * **Antidote:** Digoxin Immune Fab (Digibind). * **Management of Hyperkalemia in Digoxin Toxicity:** Avoid Calcium Gluconate (may worsen toxicity); use Digibind as the definitive treatment. * **Visual Disturbance:** Xanthopsia (yellow-green halos).

Q: Which of the following statements is WRONG about amiodarone?

It has positive ionotropic action.. Amiodarone is a Class III anti-arrhythmic drug with a complex pharmacological profile. The statement that it has positive inotropic action is **wrong** because amiodarone actually possesses **negative inotropic effects**. It acts as a myocardial depressant and can decrease cardiac contractility, which is why it must be used with caution in patients with severe heart failure. **Explanation of Options:** * **Option B (Correct):** Amiodarone is a non-competitive antagonist of alpha and beta-adrenergic receptors and also blocks calcium channels. These properties lead to a reduction in myocardial contractility (negative inotropy) rather than an increase. * **Option A:** It is indeed the **longest-acting** anti-arrhythmic. Due to its high lipid solubility and extensive tissue distribution, its elimination half-life ranges from **3 weeks to 3 months**. * **Option C:** Amiodarone is structurally related to thyroxine and contains approximately **37% iodine** by weight. This is responsible for thyroid-related side effects (hypothyroidism or hyperthyroidism). * **Option D:** **Pulmonary fibrosis** is the most serious dose-dependent toxicity associated with long-term amiodarone use, requiring regular chest X-rays and pulmonary function tests. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Primarily blocks $K^+$ channels (Class III), but also blocks $Na^+$ (Class I), $Ca^{2+}$ (Class IV), and $\beta$-receptors (Class II). * **Side Effects Mnemonic (6 P's):** **P**ulmonary fibrosis, **P**hotodermatitis (Blue-grey skin), **P**eripheral neuropathy, **P**rolonged QT interval (though rarely causes Torsades de Pointes), **P**igmentation of cornea (corneal microdeposits), and **P**roblems with Thyroid. * **Drug of Choice:** For stable Ventricular Tachycardia and rhythm control in Atrial Fibrillation.

Q: Which vitamin, in high doses, can cause macular edema and macular cyst?

Niacin. **Explanation:** **Correct Answer: D. Niacin (Vitamin B3)** Niacin, specifically in high doses used for treating dyslipidemia (usually >1.5g/day), can lead to a unique ocular toxicity known as **Niacin-induced Maculopathy**. This condition is characterized by the development of **cystoid macular edema (CME)**. The underlying mechanism involves the accumulation of fluid within the retinal layers, forming macular cysts. A key clinical feature that distinguishes this from other forms of CME is that it is typically **"angiographically silent"**—meaning there is no leakage of dye on Fluorescein Angiography (FFA), as the fluid accumulation is intracellular or due to Müller cell dysfunction rather than vascular leakage. The condition is reversible upon discontinuation of the drug. **Why other options are incorrect:** * **Vitamin A:** Chronic toxicity (Hypervitaminosis A) typically causes systemic features like dry skin, hepatosplenomegaly, and **idiopathic intracranial hypertension (pseudotumor cerebri)**, which leads to papilledema (optic disc swelling), not macular cysts. * **Vitamin D:** Toxicity primarily leads to hypercalcemia, which can cause **band keratopathy** (calcium deposits in the cornea), but it does not cause macular edema. * **Vitamin E:** High doses are generally well-tolerated but may interfere with Vitamin K metabolism, increasing the risk of bleeding; it has no known association with macular edema. **High-Yield Clinical Pearls for NEET-PG:** * **Niacin Flush:** The most common side effect of Niacin, mediated by **Prostaglandin D2** (prevented by Aspirin). * **Acanthosis Nigricans:** Can be a side effect of high-dose Niacin therapy. * **Differential for CME:** Other drugs causing Macular Edema include **Latanoprost** (Prostaglandin analogs), **Epinephrine**, and **Tamoxifen**. * **Niacin and Diabetes:** Niacin can cause hyperglycemia and should be used cautiously in diabetic patients.

Q: All are toxicities seen with amiodarone therapy except?

Productive cough. **Explanation:** Amiodarone is a Class III antiarrhythmic drug known for its high iodine content and exceptionally long half-life (approx. 25–60 days). It is notorious for causing multi-organ toxicities due to its accumulation in various tissues. **Why "Productive Cough" is the correct answer:** Amiodarone causes **Pulmonary Toxicity**, most commonly presenting as **interstitial lung disease or pulmonary fibrosis**. This typically manifests as a **dry, non-productive cough** and progressive dyspnea. A productive cough is usually indicative of an infectious process rather than the drug-induced inflammatory/fibrotic changes seen with amiodarone. **Analysis of Incorrect Options:** * **Pulmonary Fibrosis/Cirrhosis (Option A):** This is the most serious side effect. It occurs due to direct oxidative damage and phospholipidosis in the lungs. * **Corneal Micro-deposits (Option B):** These occur in almost 100% of patients on long-term therapy. They are usually asymptomatic and do not require drug discontinuation, though they can cause "halos" around lights. * **Cirrhosis of Liver (Option C):** Amiodarone is hepatotoxic. It can cause asymptomatic elevations in transaminases and, in rare cases, lead to chronic liver disease or cirrhosis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Thyroid Dysfunction:** Amiodarone can cause both **Hypothyroidism** (Wolff-Chaikoff effect) and **Hyperthyroidism** (Jod-Basedow phenomenon) due to its 37% iodine content. 2. **Skin Changes:** Can cause a distinctive **Blue-grey skin discoloration** (Photodermatitis). 3. **Monitoring:** Baseline and periodic Chest X-rays, Pulmonary Function Tests (PFTs), Liver Function Tests (LFTs), and Thyroid Function Tests (TFTs) are mandatory. 4. **Mechanism:** Primarily blocks K+ channels but also shows Class I, II, and IV actions.

Q: Maximum incidence of impotence is seen with which of the following anti-hypertensive agents?

Beta blockers. The correct answer is **Beta blockers**. Sexual dysfunction, specifically erectile dysfunction (impotence), is a well-documented side effect of traditional antihypertensive therapy, with the highest incidence associated with **Beta blockers** and **Thiazide diuretics** [1]. **1. Why Beta Blockers?** Beta blockers (especially non-selective ones like Propranolol) cause impotence through multiple mechanisms: * **Vasoconstriction:** Blockade of $\beta_2$ receptors leads to unopposed $\alpha$-adrenergic activity, causing peripheral vasoconstriction and reduced blood flow to the corpora cavernosa. * **Central Effect:** They can decrease libido by acting on the central nervous system. * **Nitric Oxide Inhibition:** Older beta blockers may interfere with the nitric oxide-mediated vasodilation required for an erection [3]. **2. Analysis of Incorrect Options:** * **CCBs (Option A):** Generally considered neutral regarding sexual function [2]. They rarely cause impotence. * **ARBs (Option C) & ACE Inhibitors (Option D):** These drugs are either neutral or potentially **beneficial**. ARBs (like Losartan) have been shown in some studies to improve sexual function by blocking the vasoconstrictive effects of Angiotensin II in the penile vasculature. **High-Yield Clinical Pearls for NEET-PG:** * **Nebivolol:** Unlike older beta blockers, Nebivolol is a highly selective $\beta_1$ blocker that promotes **Nitric Oxide (NO)** release, making it the beta blocker with the *least* risk of impotence [3]. * **Diuretics:** Among diuretics, **Chlorthalidone** and **Thiazides** are frequently associated with impotence [1]. * **Spironolactone:** Can cause impotence and gynecomastia due to its anti-androgenic effects. * **Drug of Choice:** For a hypertensive patient concerned about sexual dysfunction, **ARBs** are the preferred choice.

Q: Which antiarrhythmic drug is effective in a wide range of ventricular as well as supraventricular arrhythmias and acts mainly by prolonging the action potential?

Amiodarone. ### Explanation **Correct Option: B. Amiodarone** Amiodarone is a **Class III antiarrhythmic** agent. Its primary mechanism of action is the **blockade of potassium (K+) channels**, which leads to the prolongation of the action potential duration (APD) and the effective refractory period (ERP). While classified as Class III, Amiodarone is unique because it possesses properties of all four Vaughan-Williams classes (blocks Na+, Ca2+, and β-receptors). This "broad-spectrum" profile makes it highly effective for a wide range of arrhythmias, including both **supraventricular** (e.g., Atrial Fibrillation) and **ventricular** (e.g., Ventricular Tachycardia) arrhythmias. **Analysis of Incorrect Options:** * **A. Quinidine:** A Class IA drug. While it prolongs the action potential, it is primarily used for atrial arrhythmias and is less preferred than Amiodarone due to its significant side effect profile (e.g., Cinchonism, Torsades de pointes). * **C. Lignocaine (Lidocaine):** A Class IB drug. It **shortens** the action potential duration and is exclusively effective for **ventricular arrhythmias** (especially post-MI); it has no role in supraventricular arrhythmias. * **D. Tocainide:** Also a Class IB drug (oral analog of Lignocaine). Like Lignocaine, it is only used for ventricular arrhythmias and does not prolong the action potential. **High-Yield NEET-PG Pearls:** * **Long Half-life:** Amiodarone has an exceptionally long half-life (approx. 3–8 weeks) due to high tissue binding. * **Iodine Content:** It contains iodine, leading to thyroid dysfunction (both Hypo- and Hyperthyroidism). * **Side Effects:** Look for "Blue-grey skin discoloration," "Corneal micro-deposits," and "Pulmonary fibrosis" in clinical vignettes. * **Drug of Choice:** It is the preferred drug for rhythm control in patients with heart failure or structural heart disease.

Q: Which of the following drugs has been shown to prolong life in patients with chronic congestive heart failure but has a negative inotropic effect on cardiac contractility?

Carvedilol. **Explanation:** The correct answer is **Carvedilol**. **1. Why Carvedilol is correct:** Carvedilol is a non-selective beta-blocker with alpha-1 blocking properties. Traditionally, beta-blockers were contraindicated in heart failure due to their **negative inotropic effect** (reduction in force of contraction). However, in chronic congestive heart failure (CHF), there is chronic overactivation of the sympathetic nervous system, which leads to cardiac remodeling and apoptosis. By blocking these effects, Carvedilol reduces cardiac workload, prevents remodeling, and has been proven in trials (like COPERNICUS) to **prolong life and reduce mortality**. **2. Why other options are incorrect:** * **Digoxin:** This is a positive inotrope. While it improves symptoms and reduces hospitalization rates in CHF, it has **no proven mortality benefit** (it does not prolong life). * **Enalapril:** This is an ACE inhibitor. While it is a first-line drug that **prolongs life** in CHF, it does not have a negative inotropic effect; it works primarily by reducing preload and afterload through vasodilation. * **Furosemide:** This is a loop diuretic used for symptomatic relief of edema and congestion. It does not have a negative inotropic effect and has **no mortality benefit** in chronic CHF. **High-Yield Clinical Pearls for NEET-PG:** * **Mortality Benefit Drugs in CHF:** ACE inhibitors/ARBs, Beta-blockers (Carvedilol, Metoprolol succinate, Bisoprolol), Spironolactone (MRAs), and SGLT2 inhibitors. * **Beta-blocker Initiation:** Always start at very low doses ("Start low, go slow") only when the patient is **hemodynamically stable** (euvolemic), never during an acute decompensated phase. * **Carvedilol's unique property:** It also possesses antioxidant and anti-proliferative properties, further aiding in reversing cardiac remodeling.

Q: What is the mechanism of action of fibrates?

Inhibition of release of triglycerides and LDL. ### Explanation **Mechanism of Action of Fibrates** Fibrates (e.g., Fenofibrate, Gemfibrozil) primarily act as agonists of the **Peroxisome Proliferator-Activated Receptor-alpha (PPAR-α)**, a nuclear receptor found mainly in the liver and muscles. 1. **Why Option D is Correct:** Activation of PPAR-α leads to increased expression of **Lipoprotein Lipase (LPL)**, which enhances the catabolism of triglyceride-rich particles (VLDL). It also decreases the hepatic synthesis and release of VLDL (the precursor to LDL) and reduces the expression of ApoC-III (an LPL inhibitor). Consequently, there is a significant **reduction in plasma triglycerides** and a modest reduction in LDL. Additionally, fibrates increase the synthesis of ApoA-I and ApoA-II, which **raises HDL levels**. **Analysis of Incorrect Options:** * **Option A & B:** Inhibition of **HMG-CoA reductase** is the mechanism of **Statins** (the rate-limiting step in cholesterol synthesis). HMG-CoA synthase is an earlier enzyme in the pathway and is not a primary target for current lipid-lowering drugs. * **Option C:** Inhibition of cholesterol absorption at the brush border of the small intestine is the mechanism of **Ezetimibe**. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Fibrates are the first-line treatment for **Severe Hypertriglyceridemia** (TG >500 mg/dL) to prevent acute pancreatitis. * **Side Effects:** Myopathy and gallstones (cholelithiasis) due to increased biliary cholesterol excretion. * **Drug Interaction:** Combining fibrates (especially Gemfibrozil) with Statins significantly increases the risk of **Rhabdomyolysis** because they compete for the same glucuronidation pathway (UGT1A1/3).

Question 1

Monday disease is associated with exposure to which class of drugs?

Accepted Answer

Nitrates

Answer

Beta blockers

Answer

Calcium channel blockers

Answer

Potassium channel openers

Question 2

Which class of antihypertensive medications is primarily used in the management of angina pectoris?

Accepted Answer

Beta blocker

Answer

Alpha blocker

Answer

Diuretics

Answer

ACE inhibitors

Question 3

Which of the following conditions enhances digitalis toxicity?

Accepted Answer

Hyperkalemia

Answer

Renal failure

Answer

Hypercalcemia

Answer

Hypomagnesemia

Question 4

Which of the following statements is WRONG about amiodarone?

Accepted Answer

It has positive ionotropic action.

Answer

It is the longest-acting anti-arrhythmic drug.

Answer

It contains iodine.

Answer

It causes pulmonary fibrosis.

Question 5

Which vitamin, in high doses, can cause macular edema and macular cyst?

Accepted Answer

Niacin

Answer

Vitamin A

Answer

Vitamin D

Answer

Vitamin E

Question 6

All are toxicities seen with amiodarone therapy except?

Accepted Answer

Productive cough

Answer

Pulmonary cirrhosis

Answer

Corneal micro-deposits

Answer

Cirrhosis of liver

Question 7

Maximum incidence of impotence is seen with which of the following anti-hypertensive agents?

Accepted Answer

Beta blockers

Answer

Calcium channel blockers (CCBs)

Answer

Angiotensin II receptor blockers (ARBs)

Answer

Angiotensin-converting enzyme inhibitors (ACE inhibitors)

Question 8

Which antiarrhythmic drug is effective in a wide range of ventricular as well as supraventricular arrhythmias and acts mainly by prolonging the action potential?

Accepted Answer

Amiodarone

Answer

Quinidine

Answer

Lignocaine

Answer

Tocainide

Question 9

Which of the following drugs has been shown to prolong life in patients with chronic congestive heart failure but has a negative inotropic effect on cardiac contractility?

Accepted Answer

Carvedilol

Answer

Digoxin

Answer

Enalapril

Answer

Furosemide

Question 10

What is the mechanism of action of fibrates?

Accepted Answer

Inhibition of release of triglycerides and LDL

Answer

Inhibition of HMG-CoA reductase

Answer

Inhibition of HMG-CoA synthase

Answer

Inhibition of cholesterol absorption

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?